Two Sigma Advisers’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-14,993
| Closed | -$1.39M | – | 2995 |
|
|
2021
Q4 | $1.39M | Sell |
14,993
-32,500
| -68% | -$2.14M | ﹤0.01% | 1374 |
|
|
2021
Q3 | $2.83M | Sell |
47,493
-39,300
| -45% | -$2.32M | 0.01% | 1066 |
|
|
2021
Q2 | $5.92M | Sell |
86,793
-63,400
| -42% | -$4.13M | 0.02% | 787 |
|
|
2021
Q1 | $10.4M | Buy |
150,193
+75,700
| +102% | +$5.83M | 0.03% | 559 |
|
|
2020
Q4 | $5.72M | Buy |
74,493
+13,420
| +22% | +$1.01M | 0.02% | 768 |
|
|
2020
Q3 | $4.57M | Buy |
+61,073
| New | +$4.07M | 0.01% | 799 |
|
|
2018
Q2 | – | Sell |
-46,790
| Closed | -$1.85M | – | 2545 |
|
|
2018
Q1 | $1.85M | Sell |
46,790
-65,000
| -58% | -$2.53M | 0.01% | 1280 |
|
|
2017
Q4 | $3.8M | Sell |
111,790
-42,110
| -27% | -$1.2M | 0.01% | 957 |
|
|
2017
Q3 | $3.92M | Buy |
153,900
+38,700
| +34% | +$888K | 0.01% | 902 |
|
|
2017
Q2 | $1.94M | Buy |
115,200
+110,990
| +2,636% | +$1.52M | 0.01% | 1223 |
|
|
2017
Q1 | $61K | Buy |
4,210
+890
| +27% | +$13.2K | ﹤0.01% | 2302 |
|
|
2016
Q4 | $47K | Sell |
3,320
-110
| -3% | -$1.7K | ﹤0.01% | 2301 |
|
|
2016
Q3 | $60K | Buy |
3,430
+10
| +0.3% | +$166 | ﹤0.01% | 2167 |
|
|
2016
Q2 | $58K | Buy |
+3,420
| New | +$61.1K | ﹤0.01% | 2007 |
|
Two Sigma Advisers's ARNA Position: Q1 2022 in Review
Two Sigma Advisers sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 14,993 shares — an estimated $1.39M sold.
Two Sigma Advisers first reported a position in ARNA in Q2 2016 and held it in 14 quarters. The position peaked at $10.4M in Q1 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Two Sigma Advisers reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Two Sigma Advisers sold 14,993 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.39M.
- Two Sigma Advisers first reported a position in Arena Pharmaceuticals Inc in Q2 2016 and held it in 14 quarters.
- Two Sigma Advisers's Arena Pharmaceuticals Inc position peaked at $10.4M in Q1 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.